News Daily News FDA Grants Tirzepatide a New Indication for Obesity Management L.A. McKeown November 08, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Daily News Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow Michael O'Riordan November 02, 2023
News Daily News Pooled Cohort Equations Work in Real-world Patients, Even Outliers Yael L. Maxwell October 12, 2023
News Daily News Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study L.A. McKeown October 10, 2023
News Conference News EACTS 2023 Cardiac Surgeons Issue ‘Call to Action’ to Improve CABG Outcomes in Women Michael O'Riordan October 06, 2023
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Daily News GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters Shelley Wood September 28, 2023
News Daily News Psychosocial Stressors in White-Collar Jobs Up CHD Risk in Men Yael L. Maxwell September 22, 2023
News Daily News Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges Yael L. Maxwell September 21, 2023
News Daily News AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons L.A. McKeown September 20, 2023
News Daily News Slight Declines in Kidney Function Portend CV Trouble for Young Adults Todd Neale September 18, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets Michael O'Riordan September 14, 2023
News Daily News Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts Michael O'Riordan September 08, 2023
News Daily News AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP Todd Neale September 07, 2023
News Conference News ESC 2023 ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD Michael O'Riordan September 05, 2023
News Conference News ESC 2023 ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran Michael O'Riordan September 01, 2023